A share price of Acadia Healthcare Company Inc. [ACHC] is currently trading at $70.23, up 2.59%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ACHC shares have gain 0.34% over the last week, with a monthly amount drifted -13.18%, and not seem to be holding up well over a long-time horizon.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
On 14, March 2023, Geisinger and Acadia Healthcare Appoint Kelly Ankenbrand as CEO of Geisinger Behavioral Health Center Northeast. In a post published today on Yahoo Finance, .
From an analyst’s perspective:
Acadia Healthcare Company Inc. [NASDAQ: ACHC] stock has seen the most recent analyst activity on December 12, 2022, when Loop Capital upgraded its rating to a Buy and also boosted its price target to $95 from $90. Previously, Loop Capital started tracking the stock with Hold rating on June 17, 2022, and set its price target to $72. On September 27, 2021, SVB Leerink initiated with a Outperform rating and assigned a price target of $85 on the stock. UBS started tracking the stock assigning a Buy rating and suggested a price target of $81 on September 24, 2021. Credit Suisse upgraded its rating to a Outperform but $68 remained the price target by the analyst firm on September 20, 2021. Cowen started tracking with a Outperform rating for this stock on September 10, 2021, and assigned it a price target of $79. In a note dated August 12, 2021, Barclays initiated an Underweight rating and iterated a target price of $69 on this stock.
Acadia Healthcare Company Inc. experienced fluctuations in its stock price throughout the past year between $63.20 and $89.85. Acadia Healthcare Company Inc. [NASDAQ: ACHC] shares were valued at $70.23 at the most recent close of the market.
Analyzing the ACHC fundamentals
During the last quarter, Acadia Healthcare Company Inc. [NASDAQ:ACHC] saw sales of 675.29 billion, an improvement of 13.80%. Gross Margin for this corporation currently stands at +23.15% with Operating Margin at +17.09%, Pretax Margin comes in at +14.33%, and Net Margin reading is +10.46%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 67.92 points at the first support level, and at 65.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 71.50, and for the 2nd resistance point, it is at 72.76.
Acadia Healthcare Company Inc. [ACHC] reported earnings per share of $0.8 for its fiscal quarter that ended on 9/29/2022. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.79/share, meaning a difference of $0.01 and a surprise factor of 1.30%. By comparison, the stated earnings for the previous quarter ended on 6/29/2022 were $0.84 per share as compared to estimates of $0.78 per share, a difference of $0.06 representing a surprise of 7.70%.
Ratios To Look Out For
A current ratio of 1.30 is a noteworthy aspect of Acadia Healthcare Company Inc. [NASDAQ:ACHC]. As well, the Quick Ratio is 1.29, while the Cash Ratio is 0.25. Considering the valuation of this stock, the price to sales ratio is 2.89, the price to book ratio is 2.63 and the P/E (TTM) ratio is 23.50.
Transactions by insiders
Insider trading has also been a hot topic recently, with 11 insiders purchasing 1,461,864 shares and 6 selling 559,321 shares in the past 3 months. Recent insider trading involved GRIECO WILLIAM, Director, that happened on Sep 07 when 5000.0 shares were sold. EVP, GC and Secretary, Howard Christopher L completed a deal on Aug 08 to sell 12214.0 shares. Meanwhile, Chief Financial Officer Duckworth David M. sold 26821.0 shares on Aug 05.